期刊文献+

氨甲环酸致暂时性失明1例 被引量:3

下载PDF
导出
摘要 目的通过暂时性失明1例分析原因。方法输注注射用血凝酶1kU,氨甲环酸0.4g,垂体后叶素注射液6U静注(>10min),垂体后叶素注射液12U加生理盐水250ml。结果在次日继续静滴氨甲环酸0.4g后3min左右患者出现双眼失明,立即送至眼科,加用丹参注射液250ml静滴,尼莫地平10mg静滴,用药48h后视力恢复。结论应避免氨甲环酸与凝血酶原复合物联用,防止血栓形成,阻止暂时性失明发生。
出处 《中国实用医药》 2012年第19期201-202,共2页 China Practical Medicine
  • 相关文献

参考文献1

二级参考文献10

  • 1Alawi A,Abourjaily HM,Karas RH.Risk of Adverse Events with Concomitant use of Atorvastatin or Simvastatin and Glucose-Lowering Drugs (thiazolidinediones,metformin,sulfonylurea,insulin,and acarbose).The American Journal of Cardiology,2002,89:1308-1310.
  • 2Anders Skrondal.Interaction as Departure from Additivity in Case-Control Studies:A cautionary Note.American Journal of Epidemiology,2003,158(3):251-258.
  • 3Puijenbroek EP,Antoine CG,Egberts,et al.Signalling possible drug-drug interactions in a spontaneous reporting system:delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole.British Journal of Clinical Pharmacology,1999,47:689-693.
  • 4DuMouchel W.Daryl Pregibon.Empirical bayes screening for multi-item associations.Proc KDD 2001,ACM,NY,67-76.
  • 5Xintao Wu,Daniel Barbarā,Yong Ye.Screening and interpreting multi-item associations based on log-linear modeling.SIGKDD,2003,24-27.
  • 6G.Niklas Norén,Andrew Bate,Roland Orre,et al.Extending the methods used to screen the WHO drug safety database towards analysis of complex association and improved accuracy for rare events.Statistics in medicine,2006,25:3740-3757.
  • 7G.Niklas Norén,Rolf Sundberg,Andrew Bate,et al.A statistical methodology for drug-drug interaction surveillance.Mathematical Statistics Stockholm University,Research Report 2007:2.http://www.math.su.se/matstat.
  • 8Almenoff JS,William Dumouchel,Kindman LA,et al.Disproportionality analysis using empirical Bayes data mining:a tool for the evaluation of drug interaction in the post-marketing setting.Pharmacoepidemiololgy and drug safety,2003,12:517-521.
  • 9Norén GN,Bate A,Johansson K,et al.Duplicate detection in the WHO adverse drug reaction database.http://www.who-umc.org/graphics/9717.pdf.
  • 10Egberts AC,Meyboom RH,Puijenbroek EP.Use of measures of disproportionality in pharmacovigilance:three Dutch examples.Drug Safety,2002,25(6):453-458.

共引文献17

同被引文献26

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部